2019 Premenstrual Dysphoric Disorder (PMDD) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 39 pages | ID: 24C73912AA6EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Premenstrual Dysphoric Disorder (PMDD) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Premenstrual Dysphoric Disorder (PMDD). It presents in-depth analysis of Premenstrual Dysphoric Disorder (PMDD) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Premenstrual Dysphoric Disorder (PMDD).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Premenstrual Dysphoric Disorder (PMDD) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Premenstrual Dysphoric Disorder (PMDD)

The research work is prepared through extensive and continuous research on Premenstrual Dysphoric Disorder (PMDD) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Premenstrual Dysphoric Disorder (PMDD) patients are identified
• The report includes panorama of Premenstrual Dysphoric Disorder (PMDD) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Premenstrual Dysphoric Disorder (PMDD) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Premenstrual Dysphoric Disorder (PMDD) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Region
  2.2.2 Average Enrollment of Premenstrual Dysphoric Disorder (PMDD) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Premenstrual Dysphoric Disorder (PMDD) Treatment, 2019

3. REGION WISE PREMENSTRUAL DYSPHORIC DISORDER (PMDD) CLINICAL TRIALS

3.1 Asia Pacific Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Country
3.2 Europe Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Country
3.3 North America Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Country
3.4 Middle East and Africa Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Country
3.5 South and Central America Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Country

4. PREMENSTRUAL DYSPHORIC DISORDER (PMDD) CLINICAL TRIAL TRENDS

4.1 Start Year wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials
4.2 Phase wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials
4.3 Trial Status wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials
4.4 Trial Type wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials

5. PREMENSTRUAL DYSPHORIC DISORDER (PMDD) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Premenstrual Dysphoric Disorder (PMDD) Trials by Year
5.2 Average Enrollment in Premenstrual Dysphoric Disorder (PMDD) Trials by Phase
5.3 Average Enrollment in Premenstrual Dysphoric Disorder (PMDD) Trials by Status
5.4 Average Enrollment in Premenstrual Dysphoric Disorder (PMDD) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN PREMENSTRUAL DYSPHORIC DISORDER (PMDD) CLINICAL TRIALS

6.1 Premenstrual Dysphoric Disorder (PMDD) Trials by Sponsor Type
6.2 Premenstrual Dysphoric Disorder (PMDD) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Premenstrual Dysphoric Disorder (PMDD) Trials- Phase
7.2 Premenstrual Dysphoric Disorder (PMDD) Trials- Phase
7.3 Premenstrual Dysphoric Disorder (PMDD) Trials- Phase
7.4 Premenstrual Dysphoric Disorder (PMDD) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials and Enrolment
Figure 7: North America – Country wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials and Enrolment
Figure 9: Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Phase
Figure 10: Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Trial Status
Figure 11: Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Type
Figure 12: Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Sponsor Type
Figure 13: Premenstrual Dysphoric Disorder (PMDD) Clinical Trials by Leading Sponsors
Figure 14: Premenstrual Dysphoric Disorder (PMDD) Average Enrollment by Phase
Figure 15: Premenstrual Dysphoric Disorder (PMDD) Average Enrollment by Trial Status
Figure 16: Premenstrual Dysphoric Disorder (PMDD) Average Enrollment by Type
Figure 17: Premenstrual Dysphoric Disorder (PMDD)- Average Enrolment by Type of Sponsors
Figure 18: Premenstrual Dysphoric Disorder (PMDD)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Premenstrual Dysphoric Disorder (PMDD) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials and Enrolment
Table 5: Europe – Country wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials and Enrolment
Table 7: North America – Country wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Premenstrual Dysphoric Disorder (PMDD) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Premenstrual Dysphoric Disorder (PMDD) Average Enrollment by Phase
Table 15: Premenstrual Dysphoric Disorder (PMDD) Average Enrollment by Trial Status
Table 16: Premenstrual Dysphoric Disorder (PMDD) Average Enrollment by Type
Table 17: Premenstrual Dysphoric Disorder (PMDD)- Average Enrolment by Type of Sponsors
Table 18: Premenstrual Dysphoric Disorder (PMDD)- Enrolment by Leading Sponsors